Oncological benefits of neoadjuavant chemoradiation with gemcitabine versus upfront surgery in patients with borderline resectable pancreatic cancer: a prospective, randomized, open-label multicenter phase 2/3 Trial - Jang, J Y; Han, Y; Lee, H (Ann Surg, 2018)